ArticleNature medicine2021
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana.Vaccines · 2025Article
- Review
- Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.Journal of virology · 2023Article
- Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: a retrospective case control study.Frontiers in medicine · 2023Article
- Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease.The Journal of infection · 2022Article
- What Happens to the Immune System after Vaccination or Recovery from COVID-19?Life (Basel, Switzerland) · 2021Review
Corrections and comments
- Erratum for
Authors and funding
47 authors.
Katie J Ewer *The Jenner Institute, University of Oxford, Oxford, UK. katie.ewer@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0001-9827-9836
Jordan R Barrett *The Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-0746-1945
Sandra Belij-Rammerstorfer *The Jenner Institute, University of Oxford, Oxford, UK.
Hannah SharpeThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-1194-2429
Rebecca MakinsonThe Jenner Institute, University of Oxford, Oxford, UK.
Richard MorterThe Jenner Institute, University of Oxford, Oxford, UK.
Amy FlaxmanThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-6460-1372
Daniel WrightThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8114-1838
Duncan BellamyThe Jenner Institute, University of Oxford, Oxford, UK.
Mustapha BittayeThe Jenner Institute, University of Oxford, Oxford, UK.
Christina DoldOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nicholas M ProvineNuffield Department of Medicine, University of Oxford, Oxford, UK.
Jeremy AboagyeThe Jenner Institute, University of Oxford, Oxford, UK.
Jamie FowlerThe Jenner Institute, University of Oxford, Oxford, UK.
Sarah E SilkThe Jenner Institute, University of Oxford, Oxford, UK.
Jennifer AldersonThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Parvinder K AleyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Brian AngusNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3598-7784
Eleanor BerrieClinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Sagida BibiOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Paola CicconiOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Elizabeth A ClutterbuckOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Irina ChelyshevaOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7802-7025
Pedro M FolegattiThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5330-0240
Michelle FuskovaThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2146-4299
Catherine M GreenClinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Daniel JenkinThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3088-310X
Simon KerridgeOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Alison LawrieThe Jenner Institute, University of Oxford, Oxford, UK.
Angela M MinassianThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7832-9824
Maria MooreOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Yama MujadidiOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2342-8531
Emma PlestedOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ian PoultonThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6603-8461
Maheshi N RamasamyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2119-951X
Hannah RobinsonOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Rinn SongOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-6877-1096
Matthew D SnapeOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Richard TarrantClinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Merryn VoyseyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Marion E E WatsonThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8570-2113
Alexander D DouglasThe Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5410-7562
Adrian V S Hill *The Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-0900-9629
Sarah C Gilbert *The Jenner Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6823-9750
Andrew J Pollard *Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7361-719X
Teresa Lambe *The Jenner Institute, University of Oxford, Oxford, UK. Teresa.lambe@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0001-7711-897X
Oxford COVID Vaccine Trial Group
Funding
Medical Research Council MC_PC_19055NIAID NIH HHS HHSN272201400008CWellcome Trust 109965/Z/15/Z
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
34021278What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.